BioWorld1h
No magic with Abbott’s Amulet compared to Watchman
Three years after the U.S. FDA approval of Abbott Laboratories’ Amplatzer Amulet, results of its investigational device exemption trial failed to notably differentiate Abbott’s left atrial appendage ...
MassDevice10h
Abbott reports positive Amplatzer Amulet data in head-to-head trial with Boston Scientific’s Watchman
Abbott (NYSE:ABT) announced new data supporting its Amplatzer Amulet left atrial appendage (LAA) occluder system.
GlobalData on MSN15h
Abbott’s Amplatzer Amulet shows promise in atrial fibrillation trial
Abbott has reported late-breaking five-year positive data from a trial of its Amplatzer Amulet left atrial appendage (LAA) ...
Medpage Today on MSN20h
More Lp(a)-Reducing Tx; Cardiac Denervation for Afib; LAA Occluders at 5 Years
(JAMA Cardiology) Five-year results from the Amulet IDE trial suggested similar performance of the Amulet and Watchman 2.5 ...